Stay updated on Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedNew quick links were added to the page (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study) along with a new revision tag 'Revision: v3.6.0'. The 'Intervention / Treatment' heading formatting was updated to align with updated terminology.SummaryDifference0.4%

- Check8 days agoChange DetectedThe page revision label updated from v3.5.4 to v3.5.5, signaling a minor update to the study record's content or metadata. This reflects an update to the page's versioning and does not imply a change to the study's details.SummaryDifference0.0%

- Check15 days agoChange DetectedA related topics section was added, including 'Ovarian cancer' and 'MedlinePlus Genetics'. This addition provides readers with quick access to contextual health information related to the study.SummaryDifference0.1%

- Check22 days agoChange DetectedThe related topics panel no longer lists the disease (Ovarian cancer) and the MedlinePlus Genetics link. This changes the auxiliary context and linked resources shown on the page, while core study details remain unchanged.SummaryDifference0.1%

- Check29 days agoChange DetectedThe recruitment status changed from Recruiting to Not yet recruiting. The page now lists Ovarian cancer as the condition and adds related topics, including MedlinePlus Genetics, to provide broader context.SummaryDifference0.6%

- Check37 days agoChange DetectedRemoval of the related topic links 'Ovarian cancer' and 'MedlinePlus Genetics' from the page's related topics section. This alters the navigational links but does not affect the core trial information.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.